HomePublications

Microfluidics for pharmaceutical nanoparticle fabrication: the truth and the myth

Research output: Contribution to journalArticle

Standard

Microfluidics for pharmaceutical nanoparticle fabrication: the truth and the myth. / Hamdallah, Sherif; Zoqlam, Randa; Erfle, Peer; Blyth, Mark; Alkilany, Alaaldin; Diesel, Andreas; Qi, Sheng.

In: International Journal of Pharmaceutics, Vol. 584, 119408, 30.06.2020.

Research output: Contribution to journalArticle

Harvard

APA

Vancouver

Author

Bibtex- Download

@article{f7ccb5d3433943fbbb343e8a0fc3c4a5,
title = "Microfluidics for pharmaceutical nanoparticle fabrication: the truth and the myth",
abstract = "Using micro-sized channels to manipulate fluids is the essence of microfluidics which has wide applications from analytical chemistry to material science and cell biology research. Recently, using microfluidic-based devices for pharmaceutical research, in particular for the fabrication of micro- and nano-particles, has emerged as a new area of interest. The particles that can be prepared by microfluidic devices can range from micron size droplet-based emulsions to nano-sized drug loaded polymeric particles. Microfluidic technology poses unique advantages in terms of the high precision of the mixing regimes and control of fluids involved in formulation preparation. As a result of this, monodispersity of the particles prepared by microfluidics is often recognised as being a particularly advantageous feature in comparison to those prepared by conventional large-scale mixing methods. However, there is a range of practical drawbacks and challenges of using microfluidics as a direct micron- and nano-particle manufacturing method. Technological advances are still required before this type of processing can be translated for application by the pharmaceutical industry. This review focuses specifically on the application of microfluidics for pharmaceutical solid nanoparticle preparation and discusses the theoretical foundation of using the nanoprecipitation principle to generate particles and how this is translated into microfluidic design and operation.",
author = "Sherif Hamdallah and Randa Zoqlam and Peer Erfle and Mark Blyth and Alaaldin Alkilany and Andreas Diesel and Sheng Qi",
year = "2020",
month = jun,
day = "30",
doi = "10.1016/j.ijpharm.2020.119408",
language = "English",
volume = "584",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - Microfluidics for pharmaceutical nanoparticle fabrication: the truth and the myth

AU - Hamdallah, Sherif

AU - Zoqlam, Randa

AU - Erfle, Peer

AU - Blyth, Mark

AU - Alkilany, Alaaldin

AU - Diesel, Andreas

AU - Qi, Sheng

PY - 2020/6/30

Y1 - 2020/6/30

N2 - Using micro-sized channels to manipulate fluids is the essence of microfluidics which has wide applications from analytical chemistry to material science and cell biology research. Recently, using microfluidic-based devices for pharmaceutical research, in particular for the fabrication of micro- and nano-particles, has emerged as a new area of interest. The particles that can be prepared by microfluidic devices can range from micron size droplet-based emulsions to nano-sized drug loaded polymeric particles. Microfluidic technology poses unique advantages in terms of the high precision of the mixing regimes and control of fluids involved in formulation preparation. As a result of this, monodispersity of the particles prepared by microfluidics is often recognised as being a particularly advantageous feature in comparison to those prepared by conventional large-scale mixing methods. However, there is a range of practical drawbacks and challenges of using microfluidics as a direct micron- and nano-particle manufacturing method. Technological advances are still required before this type of processing can be translated for application by the pharmaceutical industry. This review focuses specifically on the application of microfluidics for pharmaceutical solid nanoparticle preparation and discusses the theoretical foundation of using the nanoprecipitation principle to generate particles and how this is translated into microfluidic design and operation.

AB - Using micro-sized channels to manipulate fluids is the essence of microfluidics which has wide applications from analytical chemistry to material science and cell biology research. Recently, using microfluidic-based devices for pharmaceutical research, in particular for the fabrication of micro- and nano-particles, has emerged as a new area of interest. The particles that can be prepared by microfluidic devices can range from micron size droplet-based emulsions to nano-sized drug loaded polymeric particles. Microfluidic technology poses unique advantages in terms of the high precision of the mixing regimes and control of fluids involved in formulation preparation. As a result of this, monodispersity of the particles prepared by microfluidics is often recognised as being a particularly advantageous feature in comparison to those prepared by conventional large-scale mixing methods. However, there is a range of practical drawbacks and challenges of using microfluidics as a direct micron- and nano-particle manufacturing method. Technological advances are still required before this type of processing can be translated for application by the pharmaceutical industry. This review focuses specifically on the application of microfluidics for pharmaceutical solid nanoparticle preparation and discusses the theoretical foundation of using the nanoprecipitation principle to generate particles and how this is translated into microfluidic design and operation.

U2 - 10.1016/j.ijpharm.2020.119408

DO - 10.1016/j.ijpharm.2020.119408

M3 - Article

VL - 584

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

M1 - 119408

ER -

ID: 181770663